Tag: ACE-CL-001

Two trials: acalabrutinib in CLL

Presented By

Prof. John Byrd, Ohio State University Comprehensive Cancer Centre, USA

Trial

Phase 2, ACE-CL-001, ASCEND

Conference

EHA 2020